Latin America Preventive Vaccine Market By Vaccine Type (Live, Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines And Recombinant Vector Vaccines), By End User (Paediatric And Adult Vaccines) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

Latin America Preventive Vaccine Market By Vaccine Type (Live, Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines And Recombinant Vector Vaccines), By End User (Paediatric And Adult Vaccines) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

ID: 144 | Pages: 145 | April 2018 | Region: Latin America


While the preventive vaccine accounts for only 5 % of the global pharmaceuticals market, there has been a substantial growth in the recent years as a result of rising incidences of HIV cases and cancer. World Health Organization growth estimations indicate the market may increase at a tremendous rate with the introduction of new therapeutic preventive, and adult vaccines.

Latin America Preventive Vaccine Market is estimated at $ 4.61 Billion in 2018 and is poised to reach $ 8.57 billion by 2023 with a compound annual growth rate of 13.17 %.

Vaccination is a process in which the immune system of individual is stimulated by injecting the vaccine. The vaccine Market is relatively small market compared to the pharmaceutical market and is growing at a fast rate. Many multinational companies are investing heavily in vaccine market and there are currently close to 120 new vaccines in the pipeline set to hit the market across the globe in the next few years. The vaccine market is a highly regulated market and is mostly dependent on the public purchasers and donor policies.

Increased funding for the vaccine development from the government, huge investments in the R&D department of the preventive vaccines by the major firms in the vaccine industry, technological advancements making it easier for new innovations, initiatives by NGO’s. However, there are few restrains that the market has to overcome like high capital expenditures, stringent policies by the government, high cost of treatment.

The Latin America Preventive Vaccines Market is segmented by type of vaccine as Live, attenuated vaccines, inactivated vaccines, Toxoid vaccines, Subunit vaccines, Conjugate vaccines, DNA vaccines and Recombinant vector vaccines. In addition, based on age groups the market is segmented as Paediatric Vaccine (Pneumococcal, MMR, Varicella, Hepatitis, Poliovirus, HIB and others) and Adult vaccines (Influenza, Cervical Cancer, Hepatitis, Zoster and others). And also, based on geography, Latin America Market is analysed under various regions namely, Argentina, Brazil and Mexico.

Many of the major vaccine companies have been investing heavily in research and developments resulting in new innovations in the markets. The major firms in the preventive vaccine market are Johnson and Johnson, GlaxoSmithKline, plc, Merck and Company, Bavarian Nordic, Novartis AG, MedImmune, CSL Limited, Emergent BioSolutions Inc., LLC, Pfizer, Inc., and Sanofi Pasteur.

  1. Introduction

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                           

                1.4 General Study Assumptions                                                                

  1. Research Methodology

                2.1 Introduction                                                                              

                2.2 Analysis Design                                                                         

                2.3 Research Phases                                                                      

                                2.3.1 Secondary Research                                                            

                                2.3.2 Primary Research                                                 

                                2.3.3 Econometric Modelling                                                     

                                2.3.4 Expert Validation                                                  

                2.4 Study Timeline                                                                          

  1. Overview

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                               

  1. Market Segmentation

                5.1 By Vaccine Type                                                                       

                                5.1.1 Live, Attenuated Vaccines                                                

                                5.1.2 Inactivted Vaccines                                                             

                                5.1.3 Toxoid Vaccines                                                    

                                5.1.4 Subunit vaccines                                                  

                                5.1.5 Conjugate vaccines                                                             

                                5.1.6 DNA vaccines                                                         

                                5.1.7 Recombinant vector vaccines                                                          

                5.2 By End User                                                               

                                5.2.1 Paediatric Vaccine                                               

                                                5.2.1.1 Pneumococcal                                   

                                                5.2.1.2 MMR                                     

                                                5.2.1.3 Varicella                               

                                                5.2.1.4 Hepatitis                                              

                                                5.2.1.5 Poliovirus                                             

                                                5.2.1.6 HIB                                         

                                                5.2.1.7 Others                                  

                                5.2.2 Adult Vaccines                                                      

                                                5.2.2.1 Influenza                                             

                                                5.2.2.2 Cervical Cancer                                 

                                                5.2.2.3 Hepatitis                                              

                                                5.2.2.4 Zoster                                   

                                                5.2.2.5 Others                                  

  1. Geographical Analysis

                6.1 Introduction                                                                              

                6.2 Brazil                                                                             

                6.3 Argentina                                                                    

                6.4 Mexico                                                                         

  1. Strategic Analysis

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                      

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                               

                                7.2.5 Competitive Rivalry within the Industry                                                      

  1. Market Leaders' Analysis

                8.1 GlaxoSmithKline, plc.                                                                             

                                8.1.1 Overview                                                

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                            

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Merck and Company                                                                              

                8.3 Bavarian Nordic                                                                        

                8.4 CSL Limited                                                                 

                8.5 Emergent BioSolutions Inc.                                                                  

                8.6 Novartis AG                                                                

                8.7 Johnson and Johnson                                                                             

                8.8 MedImmune, LLC                                                                    

                8.9 Pfizer, Inc.                                                                   

                8.10 Sanofi Pasteur                                                                        

  1. Competitive Landscape

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                        

                9.3 Agreements, collaborations and Joint Ventures                                                                          

                9.4 New Product Launches                                                                          

  1. Expert Opinions

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

     Appendix                                                                                           

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Latin America Preventive Vaccines Market By Region, From 2018-2023( USD Billion )
  2. Latin America Preventive Vaccines Market By Vaccine Type, From 2018-2023( USD Billion )
  3. Latin America Live, Attenuated Vaccines Market By Region, From 2018-2023( USD Billion )
  4. Latin America Inactivated Vaccines Market By Region, From 2018-2023( USD Billion )
  5. Latin America Toxoid Vaccines Market By Region, From 2018-2023( USD Billion )
  6. Latin America Subunit vaccines Market By Region, From 2018-2023( USD Billion )
  7. Latin America Conjugate vaccines Market By Region, From 2018-2023( USD Billion )
  8. Latin America DNA vaccines Market By Region, From 2018-2023( USD Billion )
  9. Latin America Recombinant vector vaccines Market By Region, From 2018-2023( USD Billion )
  10. Latin America Preventive Vaccines Market By End User, From 2018-2023( USD Billion )
  11. Latin America Paediatric Vaccines Market By Region, From 2018-2023( USD Billion )
  12. Latin America Adult Vaccines Market By Region, From 2018-2023( USD Billion )
  13. Latin America Paediatric Vaccines Market By Type, From 2018-2023( USD Billion )
  14. Latin America Pneumococcal Vaccines Market By Region, From 2018-2023( USD Billion )
  15. Latin America MMR Vaccines Market By Region, From 2018-2023( USD Billion )
  16. Latin America Varicella Vaccines Market By Region, From 2018-2023( USD Billion )
  17. Latin America Hepatitis Vaccines Market By Region, From 2018-2023( USD Billion )
  18. Latin America Poliovirus Vaccines Market By Region, From 2018-2023( USD Billion )
  19. Latin America HIB Vaccines Market By Region, From 2018-2023( USD Billion )
  20. Latin America Other Paediatric Vaccines Market By Region, From 2018-2023( USD Billion )
  21. Latin America Adult Vaccines Market By Type, From 2018-2023( USD Billion )
  22. Latin America Influenza Vaccines Market By Region, From 2018-2023( USD Billion )
  23. Latin America Cervical Cancer Vaccines Market By Region, From 2018-2023( USD Billion )
  24. Latin America Hepatitis Vaccines Market By Region, From 2018-2023( USD Billion )
  25. Latin America Zoster Vaccines Market By Region, From 2018-2023( USD Billion )
  26. Latin America Other Adult Vaccines Market By Region, From 2018-2023( USD Billion )
  27. Brazil Preventive Vaccines Market By Vaccine Type, From 2018-2023( USD Billion )
  28. Brazil Preventive Vaccines Market By End User, From 2018-2023( USD Billion )
  29. Argentina Preventive Vaccines Market By Vaccine Type, From 2018-2023( USD Billion )
  30. Argentina Preventive Vaccines Market By End User, From 2018-2023( USD Billion )
  31. Mexico Preventive Vaccines Market By Vaccine Type, From 2018-2023( USD Billion )
  32. Mexico Preventive Vaccines Market By End User, From 2018-2023( USD Billion )
  33. Brazil Paediatric Vaccines Market By Type, From 2018-2023( USD Billion )
  34. Argentina Paediatric Vaccines Market By Type, From 2018-2023( USD Billion )
  35. Mexico Paediatric Vaccines Market By Type, From 2018-2023( USD Billion )
  36. Brazil Adult Vaccines Market By Type, From 2018-2023( USD Billion )
  37. Argentina Adult Vaccines Market By Type, From 2018-2023( USD Billion )
  38. Mexico Adult Vaccines Market By Type, From 2018-2023( USD Billion )
Middle East And Africa Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth...
Asia Pacific Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, A...
Europe Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Fo...
North America Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, ...
Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts ...
Middle East And Africa Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) A...
Latin America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Asia Pacific Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Regi...
Europe Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - I...
North America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - Industry...
Pharmaceutical Gelatin Market By Function (stabilizers, Thickeners, Gelling Agents And Others) , By Source( Pig Skin, Bovine Hides, Bones And Others), By Application ( Hard Capsules, Soft Capsules, Microencapsulatio...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.